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Abstract. The geographical distribution of the metabolic syndrome (MetS) prevalence in young Mexicans (aged 17-24 years)
was estimated stepwise starting from its prevalence based on the body mass index (BMI) in a study of 3,176 undergraduate
students of this age group from Mexico City. To estimate the number of people with MetS by state, we multiplied its preva-
lence derived from the BMI range found in the Mexico City sample by the BMI proportions (range and state) obtained from
the Mexico 2006 national survey on health and nutrition. Finally, to estimate the total number of young people with MetS
in Mexico, its prevalence by state was multiplied by the share of young population in each state according to the National
Population and Housing Census 2010. Based on these figures, we estimated the national prevalence of MetS at 15.8%, the
average BMI at 24.1 (standard deviation = 4.2), and the prevalence of overweight people (BMI ≥25) of that age group at
39.0%. These results imply that 2,588,414 young Mexicans suffered from MetS in 2010. The Yucatan peninsula in the south
and the Sonora state in the north showed the highest rates of MetS prevalence. The calculation of the MetS prevalence by
BMI range in a sample of the population, and extrapolating it using the BMI proportions by range of the total population,
was found to be a useful approach. We conclude that the BMI is a valuable public health tool to estimate MetS prevalence
in the whole country, including its geographical distribution.
Keywords: Metabolic syndrome, public health, geographical distribution, young mexicans, Mexico City, Mexico.
Introduction
The metabolic syndrome (MetS) involves certain
clinical findings (dyslipidemia, hyperglycemia, hyper-
tension and obesity) and constitutes a risk factor for
diabetes and cardiovascular disease, including cardiac
arrest. It is a major public health problem worldwide,
mainly due to overfeeding and a sedentary lifestyle
(Seidell, 2000; WHO, 2000; Popkin and Gordon-
Larsen, 2004; Conrier et al., 2008; James, 2008; Low
and Chin, 2009), but the details of the interaction
between the factors involved in MetS are still largely
unknown (Varga et al., 2009). Although obesity,
defined by the World Health Organization (WHO) as
abnormal or excessive fat accumulation that may
impair health (http://www.who.int/mediacentre/fact-
sheets/fs311/en), is recognized as a major risk for early
death (Ezzati et al., 2002), its association with MetS is
not constant. The American Heart Association (AHA)
considers five associated factors (Table 1) of which
obesity is not a mandatory part (Grundy et al., 2005;
Alberti et al., 2009). Despite this, there is strong evi-
dence at the clinical as well as the biochemical levels
that abdominal adiposity plays a central role in the
development of MetS (Donath and Shoelson, 2011).
The clinical entity of MetS has been questioned
because of diagnostic imprecision (Reaven, 2005;
Simmons et al., 2010; Reaven, 2011). However, in our
opinion, MetS is still a useful definition that should be
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Parameter Cut-off level
Waist circumference
Blood pressure
Triglycerides
HDL cholesterol
Fasting glucose
≥80 cm in women; ≥90 cm in men
≥130 mm Hg systolic; ≥85 mm Hg diastolic
≥150 mg/dl
<50 mg/dl in women; <40 mg/dl in men
≥100 mg/dl
Table 1. Reference values of anthropometric and clinical param-
eters of the metabolic syndrome (definition proposed by Alberti
et al., 2009).
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considered in the evaluation framework that includes
insulin resistance pathophysiology, diabetes type 2 and
cardiovascular disease (Cornier et al., 2008). We also
believe that knowing its geographical distribution
should facilitate the design of public health strategies
to manage resources optimally.
Abdominal adiposity can be indirectly estimated
through two measures: body mass index (BMI) and
waist circumference. Both measures have weaknesses
and strengths (Szarek et al., 2009) but since the for-
mer is the more widely applied and more public
health data are available based on this parameter, we
decided to focus on BMI. Since obesity has a correla-
tion to MetS prevalence (Villalpando et al., 2007;
Ntandou et al., 2009), we investigated the differences
in BMI range by geographical frequency to estimate
how it varies depending on where in the country peo-
ple live. 
Materials and methods
In order to estimate MetS prevalence by state, data
from four sources were collected and combined: 
(i) the Mexican National Population and Housing
Census 2010 (http://www.censo2010.org.mx/)
whose data are reported aggregated in predefined
age groups;
(ii) a truncated part of the National Census 2010
including about 10% of the total records
(http://www.inegi.org.mx/est/contenidos/espanol/
soc/sis/microdatos). This part (here called the
microdata) was included because each record rep-
resents an individual person, which allowed us to
calculate proportions in the predefined census age
groups;
(iii) the Mexican 2006 National Survey on Health and
Nutrition (ENSANUT 2006) (http://www.
insp.mx/encuesta-nacional-salud-y-nutricion-
2006.html); and
(iv) a study sample of 3,176 young people aged 17-24
years with clinical and anthropometric parame-
ters available.
The National Institute of Statistics, Geography and
Informatics (Instituto Nacional de Estadística y
Geografía, INEGI), provided the two population data-
sets and Figure 1 shows schematically how all the
datasets were utilized to harvest the information
sought.
The sample
The investigation to evaluate the health of young
Mexicans was carried out from 2008 to 2010. The
study sample included a total of 3,176 undergraduate
students, 17 to 24 years-old, randomly chosen from
two public universities, one located in the eastern part,
Fig. 1. Methodology to estimate MetS prevalence in young Mexicans by state.
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the other in the northern part of the Mexico City met-
ropolitan area. All participants signed an informed
consent form.
Blood samples were taken for determination of glu-
cose, high-density lipoproteins (HDL) and triglyc-
erides. Anthropometric data (height, weight and waist
circumference + blood pressure) were collected from
each student by two physicians of the team (Murguía-
Romero et al., 2010). The blood samples were ana-
lyzed by CARPERMOR S.A. de C.V., a Mexican,
internationally certified and accredited reference labo-
ratory (http://www.carpermor.com.mx).
BMI calculation 
The BMI was calculated for the Mexico City sample
of 3,176 students and for the subjects in the records of
the Mexico ENSANUT 2006, using the well-known
formula:
BMI = weight/height2
where weight is measured in kilograms (kg) and the
height in meters (m). Following the WHO recommen-
dations, the BMI classes were divided into five groups
underweight (<18.5); normal range; (divided in two
subclasses: 18.5 to < 23.0, and 23.0 to < 25.0); pre-
obese (25.0 to <30.0), and obese (≥30.0) (http://
apps.who.int/bmi/; WHO, 1986, 1995, 2004). For both
samples, only the records of persons within the target
age range (17-24 years) were accepted for the study.
Estimating MetS prevalence
We estimated the MetS prevalence in the Mexico
City study sample using an international definition
according to Alberti et al. (2009) to create three class-
es (here referred to as “metabolic condition”).
Students showing normal reference values (Table 1)
were classified as “healthy”, those with one or two
results outside the normal as  “undefined”, and those
with three or more results outside the normal limits as
“MetS”. We further disaggregated the data, presenting
them in a 3 x 5 matrix of the percentages of people
with the various metabolic conditions by BMI class. In
order to estimate the numbers of 17-24 years old sub-
jects in each of the three classes, including those with
MetS by each state in Mexico, we extrapolated the
matrix percentages to the BMI class percentages
obtained from the ENSANUT 2006. The resulting
proportions were multiplied by the total number of
17-24 years old in the country. To estimate the total
Mexican population of the target age-range by state,
we used the data from the 2010 National Population
Census (http://www.censo2010.org.mx/) that presents
the population in 5-year groups, choosing the age-
ranges of 15-19 years and 20-24 years, and the micro-
data sample that reports the age for each individual
(http://www.inegi.org.mx/est/contenidos/espanol/soc/s
is/microdatos). The first source revealed the total num-
ber of young people by state in two age ranges, 15-19
years and 20-24 years), and the second the proportion
belonging to the age group of 17-19 years by state,
making it possible to exclude the 15-16 years age
group and thus arrive at the 17-24 years reference
group we were targeting.
Results
MetS prevalence by BMI range
The MetS prevalence in the sample of 3,176 young
people in Mexico City (Table 2, Fig. 2) is ascendant
with respect to BMI, i.e. there were more obese sub-
jects (48.6%) than underweight ones (0.6%). All BMI
classes included MetS prevalence greater than zero
and, as expected, the higher the BMI class, the greater
the MetS prevalence. 
Group of 17-24 years old Projected probability
BMI class BMI range Total Healthy Undefined* MetS Healthy Undefined* MetS
Underweight
Normal range 1
Normal range 2
Pre-obese
Obese
<18.5
18.5 - <23.0
23.0 - <25.0
25.0 - <30.0
≥30.0
162
1,344
651
725
294
95
566
153
57
4
66
741
442
510
147
1
37
56
158
143
58.6%
42.1%
23.5%
7.9%
1.4%
40.7%
55.1%
67.9%
70.4%
50.0%
0.6%
2.8%
8.6%
21.8%
48.6%
Table 2. Probabilities for young Mexicans to present the various metabolic condition disaggregated by BMI class. 
* Those with alteration in one or two of the five components of MetS.
M. Murguía-Romero et al. - Geospatial Health 6(3), 2012, pp. S43-S50S46
Population percentages by BMI range
The data from the Mexican ENSANUT 2006
allowed us to estimate the percentages of young pop-
ulation by BMI class in each state (Table 3). At the
national level, the estimated prevalence of under-
weight people was 5.7%, while those within the nor-
mal range were 55.3% and those classified as over-
weight (pre-obese + obese) were 39.0%. If the subdi-
visions are taken into account, the figures are 37.9%
for normal range 1 with 17.4% for normal range 2,
while the pre-obese and the obese were 26.5% and
12.5%, respectively.
The percentages at the national level can be seen as
the aggregation of the geographic components at the
state level (Fig. 3). As can be seen, there is a wide vari-
ation from low to high values, i.e. the underweight
class runs from 1.6% (Yucatan) to 9.5%
(Chihuahua), normal range 1 from 31.4% (Yucatan)
to 44.8% (Hidalgo), normal range 2 from 11.4%
(San Luis Potosi) to 23.5% (Puebla), pre-obese from
19.1% (Guerrero) to 35.0% (the State of Mexico),
and obese runs from 8.1% (Hidalgo) to 17.1%
(Tabasco).
Fig. 3. MetS prevalence in Mexico City’s young population (17-24 years old) grouped by BMI class. “With MetS” = young people
with the metabolic syndrome; “undefined” = young people with alteration in one or two of the five components of MetS; “healthy”
= young people with no alterations in any of the five MetS componentes.
Fig. 2. Estimated obesity prevalence in young Mexicans by state. State percentage of obese people by BMI range (BMI ≥30).
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Estimation of MetS prevalence by state
The MetS prevalence estimation based on BMI
ranges was 15.8% for the whole country, varying
from 13.3% in Chiapas to 18.4% in Quintana Roo
(Fig. 4, Table 4). The states of Sonora and Tabasco
plus those of the Yucatan peninsula (Campeche,
Quintana Roo and Yucatan) showed the highest
prevalence of MetS (>18%). Hidalgo, Nayarit and
the southern States of Chiapas and Oaxaca showed
the lowest MetS prevalence rates (<14%); while
Sinaloa state showed the highest percentage of those
regarded as healthy (28.8%). None of the states had
a proportion higher than 30% belonging to the
healthy category. The three big city states (Mexico
State, Distrito Federal and Nuevo Leon) showed
MetS prevalence rates above the national average
(15.8%). Our estimate is that 2,588,414 of the
Mexican population aged 17-24 years belong to the
MetS category (Table 4).
State Population* Underweight Normal range 1 Normal range 2 Pre-obese Obese
01 Aguascalientes
02 Baja California
03 Baja California Sur
04 Campeche
05 Coahuila
06 Colima
07 Chiapas
08 Chihuahua
09 Distrito Federal
10 Durango
11 Guanajuato
12 Guerrero
13 Hidalgo
14 Jalisco
15 México
16 Michoacán
17 Morelos
18 Nayarit
19 Nuevo León
20 Oaxaca
21 Puebla
22 Querétaro
23 Quintana Roo
24 San Luis Potosí
25 Sinaloa
26 Sonora
27 Tabasco
28 Tamaulipas
29 Tlaxcala
30 Veracruz
31 Yucatán
32 Zacatecas
MÉXICO Country
174,171
462,535
91,230
126,187
381,042
96,472
749,743
478,187
1,205,041
242,810
829,572
506,191
385,747
1,101,193
2,255,862
662,080
258,649
155,452
640,103
542,519
866,186
272,498
211,673
373,385
403,394
367,099
344,532
455,516
176,981
1,082,518
294,945
224,686
16,418,199
12,396 (7.1%)
36,442 (7.9%)
6,128 (6.7%)
3,464 (2.7%)
33,621 (8.8%)
6,460 (6.7%)
34,221 (4.6%)
45,542 (9.5%)
57,884 (4.8%)
9,182 (3.8%)
34,710 (4.2%)
23,184 (4.6%)
10,425 (2.7%)
99,714 (9.1%)
131,592 (5.8%)
44,139 (6.7%)
15,327 (5.9%)
10,463 (6.7%)
53,536 (8.4%)
27,250 (5.0%)
19,989 (2.3%)
12,433 (4.6%)
3,884 (1.8%)
26,544 (7.1%)
35,279 (8.7%)
26,221 (7.1%)
11,993 (3.5%)
26,352 (5.8%)
4,597 (2.6%)
49,206 (4.5%)
4,815 (1.6%)
20,030 (8.9%)
937,023 (5.7%)
68,181 (39.1%)
168,194 (36.4%)
30,977 (34.0%)
44,537 (35.3%)
140,089 (36.8%)
35,316 (36.6%)
320,430 (42.7%)
153,703 (32.1%)
410,451 (34.1%)
99,981 (41.2%)
305,449 (36.8%)
214,455 (42.4%)
172,767 (44.8%)
446,547 (40.6%)
817,750 (36.3%)
239,278 (36.1%)
105,376 (40.7%)
61,284 (39.4%)
221,126 (34.5%)
227,908 (42.0%)
346,474 (40.0%)
103,611 (38.0%)
71,852 (33.9%)
162,803 (43.6%)
164,118 (40.7%)
129,468 (35.3%)
122,112 (35.4%)
165,642 (36.4%)
74,125 (41.9%)
416,009 (38.4%)
92,697 (31.4%)
85,346 (38.0%)
6,218,056 (37.9%)
35,330 (20.3%)
100,917 (21.8%)
15,999 (17.5%)
21,773 (17.3%)
57,904 (15.2%)
15,504 (16.1%)
155,548 (20.7%)
89,186 (18.7%)
226,274 (18.8%)
44,889 (18.5%)
149,254 (18.0%)
102,398 (20.2%)
75,958 (19.7%)
156,075 (14.2%)
263,184 (11.7%)
123,124 (18.6%)
41,192 (15.9%)
28,400 (18.3%)
102,416 (16.0%)
106,522 (19.6%)
203,221 (23.5%)
52,842 (19.4%)
35,927 (17.0%)
42,470 (11.4%)
64,420 (16.0%)
54,082 (14.7%)
66,508 (19.3%)
67,763 (14.9%)
34,477 (19.5%)
214,714 (19.8%)
62,601 (21.2%)
38,318 (17.1%)
2,849,190 (17.4%)
40,289 (23.1%)
92,507 (20.0%)
24,169 (26.5%)
35,629 (28.2%)
97,128 (25.5%)
25,410 (26.3%)
177,325 (23.7%)
125,239 (26.2%)
347,304 (28.8%)
60,192 (24.8%)
246,442 (29.7%)
96,601 (19.1%)
95,320 (24.7%)
225,441 (20.5%)
789,552 (35.0%)
169,585 (25.6%)
75,679 (29.3%)
42,600 (27.4%)
167,591 (26.2%)
128,817 (23.7%)
213,215 (24.6%)
71,492 (26.2%)
66,997 (31.7%)
102,637 (27.5%)
90,495 (22.4%)
86,858 (23.7%)
77,411 (22.5%)
114,820 (25.2%)
44,245 (25.0%)
277,339 (25.6%)
89,085 (30.2%)
57,478 (25.6%)
4,354,892 (26.5%)
17,975 (10.3%)
64,475 (13.9%)
13,957 (15.3%)
20,784 (16.5%)
52,300 (13.7%)
13,782 (14.3%)
62,219 (8.3%)
64,517 (13.5%)
163,128 (13.5%)
28,566 (11.8%)
93,717 (11.3%)
69,553 (13.7%)
31,277 (8.1%)
173,416 (15.7%)
253,784 (11.2%)
85,954 (13.0%)
21,075 (8.1%)
12,705 (8.2%)
95,434 (14.9%)
52,022 (9.6%)
83,287 (9.6%)
32,120 (11.8%)
33,013 (15.6%)
38,931 (10.4%)
49,082 (12.2%)
70,470 (19.2%)
66,508 (19.3%)
80,939 (17.8%)
19,537 (11.0%)
125,250 (11.6%)
45,747 (15.5%)
23,514 (10.5%)
2,059,038 (12.5%)
Table 3. Percentage of BMI classes of young Mexicans by state. (Based on ENSANUT 2006 - http://www.insp.mx/encuesta-nacional-
salud-y-nutricion-2006.html). 
*Estimated number of people of the 17-24 year age group based on the National Population Census 2010 (http://www.censo2010.org.mx/)
and the microdata sample of individual records of the national census (http://www.inegi.org.mx/est/contenidos/espanol/soc/sis/microdatos/).
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Discussion
The association of MetS prevalence rates with BMI
ranges was obtained from a sample representing only
two geographic units (Mexico State and Distrito
Federal) and this association was used to extrapolate
estimates for all the other states of the country, based
on the assumption that the geographical factors
involved in the geographical variation of obesity are
the same as those for MetS.
The ENSANUT 2006 is a valuable database for
making geographical estimations for Mexico, both at
the state and the country levels; nevertheless, we sus-
pect that MetS prevalence calculated here could be
overestimated, the reason being that ENSANUT is
most probably biased due to the participation of non-
healthy people in the survey. Mexico’s MetS map (Fig.
2) shows a qualitative comparison between the states,
but more studies are needed to confirm or modify
these results with more reliable data. 
State Population Healthy Undefined* With MetS
01 Aguascalientes
02 Baja California
03 Baja California Sur
04 Campeche
05 Coahuila
06 Colima
07 Chiapas
08 Chihuahua
09 Distrito Federal
10 Durango
11 Guanajuato
12 Guerrero
13 Hidalgo
14 Jalisco
15 México
16 Michoacán
17 Morelos
18 Nayarit
19 Nuevo León
20 Oaxaca
21 Puebla
22 Querétaro
23 Quintana Roo
24 San Luis Potosí
25 Sinaloa
26 Sonora
27 Tabasco
28 Tamaulipas
29 Tlaxcala
30 Veracruz
31 Yucatán
32 Zacatecas
MÉXICO country
174,171
462,535
91,230
126,187
381,042
96,472
749,743
478,187
1,205,041
242,810
829,572
506,191
385,747
1,101,193
2,255,862
662,080
258,649
155,452
640,103
542,519
866,186
272,498
211,673
373,385
403,394
367,099
344,532
455,516
176,981
1,082,518
294,945
224,686
16,418,19
49,314 (28.3%)
128,184 (27.7%)
23,208 (25.4%)
30,036 (23.8%)
103,706 (27.2%)
25,279 (26.2%)
213,990 (28.5%)
126,733 (26.5%)
299,380 (24.8%)
65,485 (27.0%)
211,902 (25.5%)
141,572 (28.0%)
108,702 (28.2%)
312,666 (28.4%)
565,975 (25.1%)
175,696 (26.5%)
71,621 (27.7%)
43,553 (28.0%)
167,979 (26.2%)
153,172 (28.2%)
232,097 (26.8%)
71,872 (26.4%)
48,404 (22.9%)
106,009 (28.4%)
116,293 (28.8%)
93,212 (25.4%)
84,028 (24.4%)
114,901 (25.2%)
47,516 (26.8%)
287,988 (26.6%)
66,621 (22.6%)
63,441 (28.2%)
4,350,536 (26.5%)
100,287 (57.6%)
263,822 (57.0%)
52,434 (57.5%)
73,324 (58.1%)
216,706 (56.9%)
55,308 (57.3%)
435,892 (58.1%)
274,124 (57.3%)
702,397 (58.3%)
140,631 (57.9%)
485,432 (58.5%)
289,199 (57.1%)
225,259 (58.4%)
615,628 (55.9%)
1,314,328 (58.3%)
381,496 (57.6%)
150,425 (58.2%)
90,303 (58.1%)
365,234 (57.1%)
314,033 (57.9%)
509,454 (58.8%)
158,413 (58.1%)
124,270 (58.7%)
213,096 (57.1%)
228,486 (56.6%)
207,268 (56.5%)
197,455 (57.3%)
259,379 (56.9%)
103,106 (58.3%)
629,132 (58.1%)
174,213 (59.1%)
128,717 (57.3%)
9,479,250 (57.7%)
2 4,570 (14.1%)
70,529 (15.2%)
15,588 (17.1%)
22,827 (18.1%)
60,630 (15.9%)
15,885 (16.5%)
99,861 (13.3%)
77,330 (16.2%)
203,264 (16.9%)
36,694 (15.1%)
132,238 (15.9%)
75,419 (14.9%)
51,786 (13.4%)
172,899 (15.7%)
375,559 (16.6%)
104,888 (15.8%)
36,603 (14.2%)
21,596 (13.9%)
106,890 (16.7%)
75,314 (13.9%)
124,636 (14.4%)
42,213 (15.5%)
38,999 (18.4%)
54,280 (14.5%)
58,615 (14.5%)
66,619 (18.1%)
63,048 (18.3%)
81,237 (17.8%)
26,360 (14.9%)
165,398 (15.3%)
54,111 (18.3%)
32,528 (14.5%)
2,588,414 (15.8%)
Table 4. Estimated population and MetS prevalence in young Mexicans by state (based on the MetS distribution by BMI range of
the study sample (Table 2), applied to the structure of BMI ranges by state (Table 3)).
*Young people with alteration in one or two of the five components of MetS
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The finding that all BMI classes include MetS preva-
lence greater than zero implies that obesity is not a
mandatory factor of MetS. The fact that BMI classes
“underweight” and “normal range” include MetS
prevalence rates greater than zero, suggests that the
naming of the BMI ranges is inadequate in the context
of MetS. Thus, a more clear and contextualized mean-
ing of the term “normal range” is required. 
The methodology applied in this study recognizes
clearly that there is a geographical variation of obesi-
ty (and all the other BMI classes as well). MetS and
obesity have a non-homogeneous geographical distri-
bution across the Mexican territory. Some regions
present MetS prevalence higher than others resulting
in a geographical pattern that can best be appreciated
when judged from a map (Figs. 3 and 4). Many factors
are responsible for this pattern, and there is evidence
that Mexicans are genetically predisposed to MetS-
related disorders as suggested by Goodarzi et al.
(2004) and Weissglas-Volkov et al. (2010).
Particularly, the high prevalence estimated in south-
eastern Mexico could be the consequence of a genetic
factor predisposing this population to MetS (Sanchez-
Corona et al., 2004). Such genetic pre-disposal should
be seen in the context of lifestyle, e.g. the evolutionary
forces that acted on ancient Americans act differently
now as the current population is overfed, a complete-
ly different situation compared with that of 1,000
years earlier and before. Another fact to be consid-
ered with regard to the geographical distribution of
the MetS is that of the Mexican culinary diversity and
abundance, which shows vast geographical differ-
ences.
The finding of a non-homogeneous geographical
MetS distribution in Mexico is very valuable since it
emphasizes the need to adapt prevention strategies, as
well as interventions, to the regional situation. 
Conclusions
The estimated MetS prevalence for Mexico accord-
ing to the method proposed is 15.8%. This prevalence
can be geographically disaggregated, showing its vari-
ation at the state level from 13.3% to 18.4%. While
the states of the peninsula of Yucatan (Campeche,
Quintana Roo and Yucatan), plus Sonora and
Tabasco, show the highest MetS prevalence in young
Mexicans, the southern states (Chiapas and Oaxaca),
plus Hidalgo and Nayarit, present the lowest. More
than 2,5 million young people in Mexico are estimat-
ed to have MetS, which is a current challenge and a
potentially future greater risk scenario from a public
health point of view.
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Fig. 4. Estimated MetS prevalence in young Mexicans by state (MetS definition according to Alberti et al., 2009).
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